WGRX — Wellgistics Health, Inc.

Nasdaq · Consumer Discretionary · Distributors · CIK 2030763 ·
Last close
$3.82
Market Cap
$480.06M
52W High
$12.00
52W Low
$3.36
ADV30
922,354
Next earnings
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 1,559,563 170,221 -6,015,538 -7,742,597 30,127,690 51,730 45,190,139
Dec 2025 1,670,648 -7,855,824 -12,797,758 -27,852,959 30,459,449 42,571 42,907,250
Sep 2025 3,012,904 231,012 -31,548,329 -34,318,204 52,779,540 4,228,666 46,001,525
Jun 2025 7,790,865 505,752 -5,500,376 -6,672,464 54,225,015 419,942 53,319,760

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-10,855,029
Investing CF
$-881,526
Financing CF
$10,750,790
CapEx
$-881,526
Dividends Paid
Buybacks
EPS Diluted TTM
$-1.23
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-111,031,690
Inventory
$1,639,426
Receivables
$1,137,219
ST Investments
EBIT TTM
$-96,694,974
Pretax Income TTM
$-101,274,530
Interest Exp TTM
$4,579,556
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$14,033,980
EBITDA
$-53,096,984
Free Cash Flow
$-6,756,223
Enterprise Value
$28,886,720
Total Cash
$51,730
Total Debt
$28,730,920
Shares Out
125,671,251
Trailing EPS
$-42.96
Book Value
$-0.12
ROE
ROA
-79.2%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 23,337,860 -81,194,831 -101,274,530 30,459,449 42,907,250 -10,855,029
Dec 2024 18,128,831 -6,145,132 -6,856,226 57,332,650 50,598,204 -1,224,993
Dec 2023 0 -2,880,603 -2,895,684 338,364 3,238,798 -349,136
Dec 2022 32,777,728 -3,422,729 -2,743,800 0 5,250 0

Peers — same industry

TickerNameMarket CapLastDaily %
ASPN ASPEN AEROGELS INC $494.78M $5.97
WILC G WILLI FOOD INTERNATIONAL LTD $501.77M $36.02
EACO EACO CORP $510.42M $104.99
FSTR FOSTER L B CO $411.24M $39.32
BXC BlueLinx Holdings Inc. $396.82M $50.99

News headlines (Yahoo Finance, 1h cache)

Wellgistics Health Completes Reverse Split
2026-05-26 12:00 · Yahoo
Wellgistics Health Announces Reverse Stock Split
2026-05-20 22:00 · Yahoo
Wellgistics Health, Datavault AI Agree to Form DelivMeds AI
2026-05-20 14:27 · Yahoo
Wellgistics Health Reports First Quarter 2026 Financials and Provides Business Update
2026-05-19 20:10 · Yahoo
Wellgistics Health to Announce First Quarter 2026 Financials on Tuesday May 19, 2026
2026-05-15 20:01 · Yahoo
Wellgistics Health Accelerates Digital Health Expansion of its Newly Announced RPM, RTM and CCM Pilot with Planned Acquisition of WellCare Today and its Proprietary Samsung Galaxy Watch Care Monitorin
2026-05-14 19:05 · Yahoo
Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services
2026-05-13 13:05 · Yahoo
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
2026-04-14 11:05 · Yahoo
Wellgistics Health, Inc. (WGRX) Explores $105M Acquisition of Neuritek to Expand Healthcare Platform
2026-04-03 00:08 · Yahoo
Thunder Rock Capital Serves as Exclusive M&A Advisor to Neuritek Therapeutics, Inc. on $105,000,000 Proposed Acquisition by Wellgistics Health, Inc.
2026-03-25 13:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.